N-(4-Chlorbenzhydryl)piperazin

Norchlorcyclizine

HCID 9340CAS 303-26-4
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

Standard-SMILES
Clc1ccc(C(c2ccccc2)N2CCNCC2)cc1
InChIKey
UZKBSZSTDQSMDR-UHFFFAOYSA-N
Summenformel
C17H19ClN2
Durchschnittliche Molmasse
286,8 g/mol
Monoisotopische Masse
286,1236763

Namen und Bezeichner

Bevorzugter Name
Norchlorcyclizine
IUPAC
1-[(4-chlorophenyl)-phenylmethyl]piperazine
Lokaler Name
N-(4-Chlorbenzhydryl)piperazin
Englischer Name
1-(4-Chlorobenzhydryl)piperazine
Summenformel
C17H19ClN2
Molmasse
286.8

Namen und Synonyme

1-(4-Chlorobenzhydryl)piperazine303-26-4NorchlorcyclizineN-(p-Chlorobenzhydryl)piperazine4-(4-Chlorobenzhydryl)piperazineN-(4-Chlorobenzhydryl)piperazinePiperazine, 1-[(4-chlorophenyl)phenylmethyl]-Piperazine, 1-((4-chlorophenyl)phenylmethyl)-T875VN0D6E1-(4-Chloro-alpha-phenylbenzyl)piperazine1-(alpha-Phenyl-4-chlorobenzyl)piperazineNSC-86164
Weitere Namen anzeigen
Cetirizine EP Impurity AHydroxyzine Related CoMpound A1-[(4-CHLORO-PHENYL)-PHENYL-METHYL]-PIPERAZINENSC 8616USP CBHPNSC 86164UNII:T875VN0D6EAKOS BBS-00003606Cetirizine USP A
DTXSID00891490RefChem:854707DTXCID70220253206-137-41-((4-chlorophenyl)(phenyl)methyl)piperazine130018-88-11-[(4-Chlorophenyl)(phenyl)methyl]piperazine1-[(4-Chlorophenyl)phenylmethyl]piperazine

Datenbank-Bezeichner

CAS
303-26-4
PubChem CID
9340
DTXSID
DTXSID00891490
ChEMBL
CHEMBL81324
UNII
T875VN0D6E
EC Number
206-137-4
Nikkaji
J50.575G

Eigenschaften

Berechnete Struktureigenschaften

XLogP
3,4
Polarare Oberfläche (TPSA)
15,3 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
3
Schwere Atome
20

Experimentelle und physikochemische Eigenschaften

Collision Cross Section168.4 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physikochemische Eigenschaften

Schmelzpunkt
65 · 65-70 °C (lit.)
Siedepunkt
178 · 178-180 °C/0.5 mmHg (lit.)
Dichte
1.0912 · 1.0912 (rough estimate)
Dampfdruck
0 Pa · 0Pa at 25℃
Brechungsindex
1.5749 · 1.5749 (estimate)
Flammpunkt
230 °F · >230 °F

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Warning

H302 (25%): Harmful if swallowed [Warning Acute toxicity, oral]；H315 (94.6%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (92.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H335 (89.3%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]；H361 (19.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 56 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Regulatory InformationStatus: Cease Manufacture Update: 19-12-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/21468；Status: Active Update: 20-03-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/23014
Hazard Classes and CategoriesAcute Tox. 4 (25%)；Skin Irrit. 2 (94.6%)；Eye Irrit. 2 (92.9%)；STOT SE 3 (89.3%)；Repr. 2 (19.6%)

Regulatorische Informationen

Regulatory InformationStatus: Cease Manufacture Update: 19-12-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/21468；Status: Active Update: 20-03-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/23014

Sicherheitsdaten

wgk
3
hs_code
29339900
RTECS-Nr.
TL1772000
risk_code
36/37/38
hazard_code
Xi
hazard_note
Irritant

Chemie und Industrie

Verwendung und Herstellung

Use ClassificationPharmaceuticals -> Transformation products
Darstellung · 1 Eintrag

synthetischePreparation of 1-[(4-chlorophenyl)phenylmethyl]piperazine. (CPMP)About 0.5 mL of DMF, 0.1 g of KI and 10 g (0.12 mol) of piperazine were mixed with 15 mL of toluene and heated to 80oC for 0.5 h. This mixture at 80oC was mixed with 4-CBC in toluene and the temperature was maintained at 80oC for a period of 2 h followed by refluxing at the same temperature for 12h. The reaction mixture was then cooled to 20oC. The toluene layer was washed twice with 20 mL of water and treated with HCl (15 mL conc. HCl in 5mL of water) at 5-10oC. The reaction mixture was filtered and the aqueous layer was separated from the filtrate. About 10 mL of toluene and 10 mL of methylene dichloride (MDC) washes were given to the aqueous layer and neutralized with 22 mL of 30 % NaOH solution at 10oC and maintained at 20oC for 2h. The solid compound formed was filtered, sucked and dried at 50oC for 3 h.Yield: 92 %; m.p: 63-65oC.

Vor- und nachgelagerte Produkte

Anbieter50 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
天津始加生物医药科技有限公司15022261580 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
上海泰矶林实业有限公司02150630626 17717886015 · [email protected]

Zugehörige Reaktionen

85
Reaktionsaufzeichnung erstellen

Verknüpfte Notizen

Wird geladen…